The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

PURPOSE: By applying the principles of real-time biopsy, biomarker-based, adaptively randomized studies in non–small-cell lung cancer (NSCLC) established by the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial, we conducted BATTLE-2 (BATTLE-2 Program: A...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Papadimitrakopoulou, Vassiliki, Lee, J. Jack, Wistuba, Ignacio I., Tsao, Anne S., Fossella, Frank V., Kalhor, Neda, Gupta, Sanjay, Byers, Lauren Averett, Izzo, Julie G., Gettinger, Scott N., Goldberg, Sarah B., Tang, Ximing, Miller, Vincent A., Skoulidis, Ferdinandos, Gibbons, Don L., Shen, Li, Wei, Caimiao, Diao, Lixia, Peng, S. Andrew, Wang, Jing, Tam, Alda L., Coombes, Kevin R., Koo, Ja Seok, Mauro, David J., Rubin, Eric H., Heymach, John V., Hong, Waun Ki, Herbst, Roy S.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2016
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065110/
https://ncbi.nlm.nih.gov/pubmed/27480147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.66.0084
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki